Javascript must be enabled to continue!
Immunoterapian aurrerapenak melanoma metastasikoaren aurka
View through CrossRef
Melanoma melanozitoak gaiztotzearen ondorioz sorturiko larruazaleko minbizi mota bat da. Azken hamarkadan gaixotasun horrek izandako intzidentziaren igoera dela-eta, garrantzi kliniko, sozial eta ekonomiko handia sortu du. Melanomaren tratamendua desberdina da tumore motaren eta haren estadioaren arabera, bai eta gaixoaren osasun-egoeraren eta adinaren arabera ere. Melanomaren tratamendu klasikoen artean, kirurgia, kimioterapia eta erradioterapia nagusitzen dira, baita zuzendutako terapia molekularra ere. Horiek, albo-ondorio larriak ekartzeaz gain, hainbat gaixorengan ez dute eraginik. Azken urteotan, immunoterapian oinarritutako medikamentuak indar handia hartzen ari dira. Terapia biologikoa izenez ezagutzen dena ere, gorputzaren defentsa naturalak minbiziari aurre egiteko estimulatzen dituen minbiziaren tratamendu mota bat da. Gorputzak berak ekoiztutako edo laborategi batean egindako substantziak erabiltzean datza sistema immunitarioaren funtzioa hobetzeko edo zaharberritzeko.
Udako Euskal Unibertsitatea
Title: Immunoterapian aurrerapenak melanoma metastasikoaren aurka
Description:
Melanoma melanozitoak gaiztotzearen ondorioz sorturiko larruazaleko minbizi mota bat da.
Azken hamarkadan gaixotasun horrek izandako intzidentziaren igoera dela-eta, garrantzi kliniko, sozial eta ekonomiko handia sortu du.
Melanomaren tratamendua desberdina da tumore motaren eta haren estadioaren arabera, bai eta gaixoaren osasun-egoeraren eta adinaren arabera ere.
Melanomaren tratamendu klasikoen artean, kirurgia, kimioterapia eta erradioterapia nagusitzen dira, baita zuzendutako terapia molekularra ere.
Horiek, albo-ondorio larriak ekartzeaz gain, hainbat gaixorengan ez dute eraginik.
Azken urteotan, immunoterapian oinarritutako medikamentuak indar handia hartzen ari dira.
Terapia biologikoa izenez ezagutzen dena ere, gorputzaren defentsa naturalak minbiziari aurre egiteko estimulatzen dituen minbiziaren tratamendu mota bat da.
Gorputzak berak ekoiztutako edo laborategi batean egindako substantziak erabiltzean datza sistema immunitarioaren funtzioa hobetzeko edo zaharberritzeko.
Related Results
ALLOSTERIC MODULATION OF AURKA KINASE ACTIVITY BY ARKIN-A VIA DYNAMIC CORRELATION NETWORK ANALYSIS
ALLOSTERIC MODULATION OF AURKA KINASE ACTIVITY BY ARKIN-A VIA DYNAMIC CORRELATION NETWORK ANALYSIS
Protein phosphorylation and post-translational modification by protein kinases are crucial cell signaling and regulatorysystems. AurkA, a serine/threonine kinase, controls mitotic ...
Contribution of AurkA/TPX2 Overexpression to Chromosomal Imbalances and Cancer
Contribution of AurkA/TPX2 Overexpression to Chromosomal Imbalances and Cancer
The AurkA serine/threonine kinase is a key regulator of cell division controlling mitotic entry, centrosome maturation, and chromosome segregation. The microtubule-associated prote...
AURKA destruction is decoupled from its activity at mitotic exit but suppresses interphase activity
AURKA destruction is decoupled from its activity at mitotic exit but suppresses interphase activity
Abstract
Activity of AURKA is controlled through multiple mechanisms including phosphorylation, ubiquitin-mediated degradation, and allosteric in...
Abstract LB163: Germline pathogenic variants in melanoma patients
Abstract LB163: Germline pathogenic variants in melanoma patients
Abstract
Background: The etiology of melanoma has generally been thought to be exposure to UV radiation (sun and sun tanning lamps). However, the percent of melanoma...
The Risk of Subsequent Invasive Melanoma after a Primary in Situ or Invasive Melanoma in a High Incidence Country (New Zealand)
The Risk of Subsequent Invasive Melanoma after a Primary in Situ or Invasive Melanoma in a High Incidence Country (New Zealand)
Abstract
Background
Patients with invasive melanoma are at increased risk of developing subsequent invasive melanoma, but the ri...
Divergent pathways of melanoma development: evidence from a Southern European cohort
Divergent pathways of melanoma development: evidence from a Southern European cohort
Nevus counts in the divergent pathway model of melanoma development have been studied mainly in patients in Australia. Our aim was to compare nevus counts and the melanoma subtype ...
Precursors of skin melanoma (melanoma-sensitive nevi)
Precursors of skin melanoma (melanoma-sensitive nevi)
Interest in melanoma precursors, or melanoma-sensitive skin nevi, has not lost its relevance for many years due to the steady increase of skin melanoma morbidity in recent decades ...
Abstract 1297: The heritability of melanoma differs between light- and dark-skinned individuals of European descent
Abstract 1297: The heritability of melanoma differs between light- and dark-skinned individuals of European descent
Abstract
Melanoma is strongly associated with exposure to ultraviolet radiation (UV). The prevalence of melanoma is much higher in lighter-skinned Caucasians as comp...

